Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Nov;18(11):3121-3124.
doi: 10.1111/jth.15061.

Studies on hemostasis in COVID-19 deserve careful reporting of the laboratory methods, their significance, and their limitations

Michael Hardy  1   2 , Jonathan Douxfils  3   4 , Marion Bareille  1 , Sarah Lessire  2 , Isabelle Gouin-Thibault  5 , Pierre Fontana  6 , Thomas Lecompte  6 , François Mullier  1
Affiliations
Comment

Studies on hemostasis in COVID-19 deserve careful reporting of the laboratory methods, their significance, and their limitations

Michael Hardy et al. J Thromb Haemost. 2020 Nov.
No abstract available

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Correlation between anti‐Xa levels as measured with two different chromogenic anti‐Xa assays and the endogenous thrombin potential (ETP) in plasma samples from patients treated with heparin. A, Correlation between the two chromogenic anti‐Xa assays depending on the type of heparin in the sample. The Biophen Heparin LRT overestimates the anti‐Xa level of UFH samples compared to the STA‐Liquid anti‐Xa. B, Correlation between the anti‐Xa levels in LMWH samples and the ETP. A progressive inhibition of TG is observed as measured anti‐Xa levels increase. TG was studied with the ST‐Genesia device using the STG‐DrugScreen reagent and results were normalized using a reference plasma provided with STG‐DrugScreen reagent. Each subject is represented by a different symbol
See this image and copyright information in PMC

Comment in

Comment on

References

    1. Nougier C., Benoit R., Simon M., et al. Hypofibrinolytic state and high thrombin generation may play a major role in SARS‐CoV2 associated thrombosis. J Thromb Haemost. 2020 doi: 10.1111/jth.15016. - DOI - PMC - PubMed
    1. Hollestelle M.J., van der Meer F.J.M., Meijer P. Quality performance for indirect Xa inhibitor monitoring in patients using international external quality data. Clin Chem Lab Med. 2020 doi: 10.1515/cclm-2020-0130. - DOI - PubMed
    1. Hardy M., Lecompte T., Douxfils J., et al. Management of the thrombotic risk associated with COVID‐19: guidance for the hemostasis laboratory. Thromb J. 2020 doi: 10.1186/s12959-020-00230-1. - DOI - PMC - PubMed
    1. Douxfils J., Morimont L., Bouvy C., et al. Assessment of the analytical performances and sample stability on ST Genesia system using the STG‐DrugScreen application. J Thromb Haemost. 2019;17:1273–1287. - PMC - PubMed
    1. Ranucci M., Baryshnikova E. Sensitivity of viscoelastic tests to platelet function. J Clin Med. 2020;9 - PMC - PubMed